ASHLEY TURNER: Open Payments
NPI 1952876518 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 34 payments from 16 companies in 2025. Trend: 2023 $639 · 2024 $551 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 9 | $361 |
| Actelion Pharmaceuticals US, Inc. | 6 | $175 |
| Merck Sharp & Dohme LLC | 1 | $110 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Astellas Pharma US Inc | 1 | $33 |
| Melinta Therapeutics, LLC | 2 | $33 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
Products named: Tyvaso, UPTRAVI, Orenitram, LifeVest, LIVTENCITY, Remodulin, JASCAYD, Cresemba.
Industry payments across DC — which companies pay providers there.
